2,745
Views
496
CrossRef citations to date
0
Altmetric
Research Article

Grey Goo on the Skin? Nanotechnology, Cosmetic and Sunscreen Safety

, , &
Pages 251-277 | Published online: 10 Oct 2008

REFERENCES

  • Afshari A., Matson. U., Ekberg. L.E. Characterisation of indoor sources of fine and ultrafine particles: A study conducted in a full-scale chamber. Indoor Air 2005; 15(2)141–150
  • AFSSET. Agence Francaise de Sécurité Sanitaire de l'Environnement et du Travail. Les nanomateriaux: Effets sur la santé humaine et sur l'environnement. 2006, July 2006. Available at: http://www.afsset.fr
  • Alvarez-Roman R., Barre G., Guy R.H., Fessi H. Biodegradable polymer nanocapsules containing a sunscreen agent: Preparation and photoprotection. Eur. J. Pharm. Biopharm. 2001; 52: 191–195
  • Alvarez-Roman R., Naik A., Kalia Y. N., Guy R. H., Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm. Res. 2004a; 21(10)1818–1825
  • Alvarez-Roman R., Naik A., Kalia Y. N., Guy R. H., Fessi H. Skin penetration and distribution of polymeric nanocapsules. J. Contr. Release 2004b; 99(1)53–62
  • Amstutz H. C., Campbell P., Kossowsky N., Clarke I. C. Mechanism and clinical significance of wear debris-induced osteolysis. Clin. Orthopaed. Related Res. 1992; 276: 7–18
  • Anonymous. Study shows nanoparticles in sun cream may affect mice brain cells. 2006, Cosmetics.design.com. 21 June 2006. Available at: http://www.cosmeticsdesign.com/news
  • Ball P. Nanotechnology in the firing line. 2003, Article at: http://nanotechweb.org/articles/society/2/12/1
  • Beckett W. S., Chalupa D. F., Pauly-Brown A., Speers D. M., Stewart J. C., Frampton M. W., Utell M. J., Huang L. S., Cox C., Zareba W. Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: a human inhalation study. Am. J. Respir. Crit. Care Med. 2005; 171(10)1129–1135
  • Bennat C., Müller-Goymann C.C. Skin penetration and stabilisation of formulations containing microfine titanium dioxide and a physical UV filter. Int. J. Cosmet. Sci. 2000; 22: 271–283
  • Benson H. A.E. Transdermal drug delivery: Penetration enhancement techniques. Curr. Drug Deliv. 2005; 2: 23–33
  • Bermudez E., Mangum J. B., Asgharian B., Wong B. A., Reverdy E., Janszen D. B., Hext P. M., Warheit D. B., Everitt J. I. Long-term pulmonary responses of three laboratory rodent species to subchronic inhalation of pigmentary TiO2 particles. Toxicol. Sci. 2002; 70: 86–97
  • Bermudez E., Mangum J. B., Wong B. A., Asgharian B., Hext P. M., Warheit D. B., Everett J. J. Pulmonary responses of mice, rats and hamsters to subchronic inhalation of ultrafine TiO2 particles. Toxicol. Sci. 2004; 77: 347–357
  • BfR. Bundesamt für Risikobewertung. Berlin, Germany. 2006, Nanotechnologie und Lichtschutz (Nanotechnology and UV Protection), 24 February, 2006. At http://www.bfr.bund.de
  • Blundell G., Henderson H. J., Price E. W. Soil particles in the tissues of the foot in endemic elephantiasis of the lower legs. Ann. Trop. Med. Parasitol. 1989; 83: 381–385
  • Borm P. J.A., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R. P.F., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., Oberdörster E. The potential risks of nanomaterials: A review conducted out for ECETOC. Particle Fibre Toxicol. 2006; 3(11), (in press). Doi: 10.1186/1743-8977-3-11.
  • Breme H. J., Helsen J. A. Metals and Implants. Metals as Biomaterials, H.J. Breme. Wiley, Chichester 1998; 37–72
  • Brown D. M., Wilson M. R., MacNee W., Stone V., Donaldson K. Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines. Toxicol. Appl. Pharmacol. 2001; 175: 191–199
  • Brown M. B., Martin G. P., Jones S. A., Akomeah F. K. Dermal and transdermal drug delivery systems: Current and future prospects. Drug Deliv. 2006; 13(3)175–187
  • Brunke R. A., Charlet E. Production and identification of liposomes, sphingosomes and nanoparticles. Kosmetika, Aerosole Parfümerie 1991; 64(14)514–517
  • Cai R., Hashimoto K., Itoh K., Kubota Y., Fujishima A. Photo-killing of malignant cells with ultrafine TiO2 powder. Bull. Chem. Soc. Jpn. 1991; 64: 1268–1273
  • Castor T. P. Phospholipid nanosomes. Curr. Drug Deliv. 2005; 2(4)329–340
  • Chen Y., Chen J., Dong J., Jin Y. X. Comparing study of the effect of nanosized silicon dioxide and microsized silicon dioxide on fibrogenensis in rats. Toxicol. Ind. Health 2004; 20: 21–27
  • Choi M. J., Maibach H. I. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol. Physiol. 2005; 18: 209–219
  • Choi M. G., Koh H. S., Kuess D., O'Connor D., Mathur A., Truskey G. A., Rubin J., Zhou D. X., Sung K. L. Effects of titanium particle size on osteoblast functions in vitro and in vivo. Proc. Natl. Acad. Sci. USA 2005; 102(12)4578–4583
  • Corachan M., Tura J. M., Campo E., Soley M., Traveria A. Podoconiosis in Aequatorial Guinea. Report of two cases from different geological environments. Top. Geogr. Med. 1988; 40: 359–364
  • Cormier M., Trautman J., Kim H. L. 2001, Skin treatment apparatus for sustained transdermal drug delivery. USP WO 01/41864 A1.
  • Crichton M. Prey. Harper Collins, New York 2001
  • Cross S. E., Innes B., Roberts M. S., Tsuzuki T., Robertson T. A., McCormick P. Human skin penetration of sunscreen nanoparticles: In vitro assessment of a novel micronised zinc oxide formulation. Skin Pharmacol. Physiol. 2007, (in press)
  • CSTEE. EU Scientific Committee on Toxicity, Ecotoxicity and the Environment. 2003, Opinion on the risk assessment of zinc metal, zinc chloride, sulphate, distearate, phosphate and zinc oxide. Adopted by the CSTEE during the 39th plenary meeting, 10 September 2003. Available at: http://europa.eu.int/comm/health
  • Diembeck W., Beck H., Benech-Kieffer F., Courtellement P., Dupuis J., Lovell W., Paye M., Spengler J., Steiling W. Test guidelines for in vitro assessment of dermal absorption and percutaneous penetration of cosmetic ingredients. Food Chem. Toxicol. 1999; 37: 191–205
  • Drexler E. Engines of Abundance, Engines of Creation 1986, Details of the Grey Goo Theory at: http://www.greenlibdems.org.uk/articles/8.html
  • Dufour E. K., Kumaravel T, Nohynek G. J., Kirkland D., Toutain H. Clastogenicity, photo-clastogenicity or pseudo-photo-clastogenicity? Genotoxic effects of ZnO in the dark, in pre-irradiated or simultaneously irradiated Chinese hamster ovary cells. Mutat. Res. 2006; 607: 215–224
  • Du Plessis J., Ramachandran C., Weiner N., Müller D. G. The influence of particle size of liposomes on the deposition of drug into skin. Int. J. Pharm. 1994; 103: 277–282
  • Dussert A. S., Gooris E. Characterisation of the mineral content of a physical sunscreen emulsion and its distribution onto human stratum corneum. Int. J. Cosmet. Sci. 1997; 19: 119–129
  • ECETOC. Contact sensitisation: classification according to potency. 2003, Technical Report No. 87, ECETOC, Brussels, Belgium, April 2003. Available at: http://www.ecetoc.org
  • ECETOC. Workshop on the testing strategies to establish the safety of nanomaterials. 2005, Barcelona, Spain. 7–8 November, 2005. Workshop Report No. 7. Available at: http://www.ecetoc.org
  • El Maghraby G.M., Williams A. C., Barry B. W. Can drug-bearing liposomes penetrate intact skin?. J. Pharm. Pharmacol. 2006; 58(4)415–429
  • FOE. Friends of the Earth. Nanomaterials, sunscreens and cosmetics: Small Ingredients, Big Risks. 2006a, May. Available at: http://www.foe.org
  • FOE. Nanoparticles in sunscreens stress brain cells. 2006b, Available at: http://www.foe.org
  • Gamer A., Leibold E., van Ravenzwaay B. The in vitroabsorption of microfine ZnO and TiO2 through porcine skin. Toxicol. In Vitro 2006; 20(3)301–307
  • Ganesan M., Weiner N. Influence of liposomal drug entrapment on percutaneous absorption. Int. J. Pharm. 1984; 20: 134–154
  • Garnett M. C., Kallinteri P. Nanomedicines and nanotoxicology: some physiological principles. Occup. Med. 2006; 56(5)307–311
  • Geiser M., Rothen-Rutishauser B., Kapp N., Schürch S., Kreyling W., Schulz H., Semmler M., Imhof V., Gehr P. Ultrafine particles cross cellular membranes by non-phagocytotic mechanisms in lungs and in cultured cells. Environ. Health Perspect. 2005; 113(11)1555–1560
  • Gontier E., Habchi C., Pouthier T., Aguer P., Barberet P., Barbotteau Y., Incerti S., Ynsa M. D., Surleve-Bazeille J.E., Moretto P. Nuclear microscopy and electron microscopy studies of percutaneous penetration of nanoparticles in mammalian skin. 34th EDSR Meeting 2004, Abstract 64.
  • Gopee N. V., Roberts D. W., Webb P., Cozart C., Siitonen P., Warbritton A. R., Walker N. J., Yu W. W., Colvin V. L., Howard P. C. Penetration of nanoscale quantum dots in dermabraded mouse skin. 2006, 2006 FDA Science Forum, Abstract B-38, 27 March. At: http://www.cfsan.fda.gov
  • Görög P., Pearson J. D., Kakkar V. V. Generation of reactive oxygen metabolites by phagocytosing endothelial cells. Artherosclerosis 1988; 72(1)19–27
  • Gottbrath S., Mueller-Goymann C.C. Penetration and visualisation of titanium dioxide microparticles in human stratum corneum—Effect of different formulations on the penetration of titanium dioxide. SOFW J 2004; 129: 11–14, 16–17. Abstract No 64, 34th European Dermatological research Meeting, Vienna, Austria, 9–11, September, 2004
  • Greenpeace. Future Technologies, Today's Choices. 2003, July 2003. At http://www.greenpeace.org.uk
  • Gunther C., Kecskes S., Staks T., Tauber U. Percutaneous absorption of methylprednisolone aceponate following topical application of Avantan lotion on intact, inflamed and stripped skin of male volunteers. Skin Pharmacol. Appl. Skin Physiol. 1998; 11(1)35–42
  • Gurr J. R., Wang A. S.S., Chen C. H., Jan K. Y. Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchila epithelial cells. Toxicology 2005; 213: 66–73
  • Hardman R. A toxicologic review of quantum dots: Toxicity depends on physicochemical and environmental factors. Environ. Health Perspect. 2006; 114: 165–172
  • Hexte P. M., Tomenson J. A., Thompson P. A. Titanium dioxide: Inhalation toxicity and epidemiology. Ann. Occup. Hyg. 2005; 49(6)461–472
  • Hirakawa K., Bauer T. W., Stulberg B. N., Wilde A. H. Comparison and quantification of wear debris of failed total hip and knee arthroplasty. J. Biomed. Mater. Res. 1996; 31: 257–263
  • Hoet P. H.M., Brüske-Hohlfeld I., Sata O. V. Nanoparticles—Known and unknown health risks. J. Nanotechnol. 2004; 2(12)1–15
  • Honeywell-Nguyen P. L., Gooris G. S., Bouwstra J. A. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J. Invest. Dermatol. 2004; 123(5)902–910
  • Hostynek J. J. Factors determining percutaneous metal absorption. Food Chem. Toxicol. 2003; 41: 327–345
  • Hussain S. M., Hess K. L., Gearhart J. M., Geiss K. T., Schlager J. J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 2005; 19(7)975–983
  • ICH. International Conference on Harmonisation. 1996, ICH Topic S2A. Genotoxicity: Guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals. 1 April, 1996. At: http://www.emea.eu.int
  • ICH. Notes for Guidance on Repeated Dose Toxicity. 2000, CPMP (Committee for Proprietary Medicinal Products). EMEA, London, 27 July. At http://www.emea.eu.int
  • ICTA. International Center of Technology Assessment. 2006, Legal Petition on FDA's Regulation of Nanoparticles and Nanomaterials Production. FDA Docket No. 2006P-0210/CP 1, 2006. At: http://www.icta.org/nanotech
  • ILSI. The relevance of the rat lung response to particle overload for human risk assessment: A workshop consensus report. Inhal. Toxicol. 2000; 12: 1–17
  • IRSST. Institute de recherche Robert-Sauvé en santé et sécurité du travail. 2006, Health Effects of Nanoparticles. Report R-451. Montréal, Quebec, Canada. Available at http://www.irsst.qc.ca
  • Jani P. U., McCarthy D.E., Florence A. T. Titanium dioxide (rutile) particle uptake from the rat GI tract and translocation to systemic organs after oral administrations. Int. J. Pharm. 1994; 105: 157–168
  • Jowsey I. R., Basketter D. A., Westmoreland C., Kimber I. A future approach to measuring relative skin sensitising potential: A proposal. J. Appl. Toxicol. 2006; 26(4)341–350
  • Junginger H. E., Hofland H. E.J., Bouwstra J. A. Liposomes and niosomes: Interactions with human skin. Cosm. Toiletries 1991; 106: 45–50
  • Kim. S., Lim Y. T., Soltesz E. G., De Grand A.M., Lee J., Nakayama A., Parker J. A., Mihaljevic T., Laurence R. G., Dor D. M., Cohn L. H., Bawendi M. G., Frangioni J. V. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 2004; 22: 93–97
  • Kimber I., Basketter D. A., Butler M., Garrigue J. L., Gerberick G. F., Newsome C., Steiling W., Vohr H. W. Classification of contact allergens according to potency: Proposals. Food Chem. Toxicol. 2003; 41(12)1799–1809
  • Kogan A., Garti N. Microemulsions as transdermal drug delivery vehicles. Adv. Coll. Interface Sci. 2006, in press. Advance electronic copy at: http://www.sciencedirect.com/science/journals/ (doi: 10.1016/j.cis.2006.05.014).
  • Kohli A. K., Alpar. H.O. Potential use of nanoparticles for transcutaneous vaccine delivery: Effect of particle size and charge. Int. J. Pharm 2004; 275: 13–17
  • Korting H. C., Zienecke H., Schäfer-Korting M., Braun-Falco O. Liposome encapsulation improves efficacy of betamethasone dipropionate in atopic eczema but not in psoriasis vulgaris. Eur. J. Clin. Pharmacol. 1990; 39(4)349–351
  • Korting H. C., Schmid M. H., Hartinger A., Maierhofer G., Stolz W., Braun-Falco O. Evidence for the phagocytosis of intact oligomellar liposomes by human keratinocytes in vitro and consecutive intracellular disintegration. J. Microencapsul. 1993; 10: 223–228
  • Kreilgard M. Influence of microemulsions on cutaneous drug delivery. Adv. Drug Deliv. Rev. 2002; 54(Suppl. 1)s77–s98
  • Kurath M., Maasen S. Toxicology as a nanoscience?—Disciplinary identities reconsidered. Particle Fibre Toxicol. 2006; 3: 6, 2006. Available at: http://www.particleandfibretoxicology.com
  • Lademann J., Weigmann H. J., Rickmeier C. H., Barthelmes H., Schaefer H., Mueller G., Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol. Appl. Skin Physiol. 1999; 2: 247–256
  • Lademann J., Otberg N., Richter H., Weigmann H. J., Lindemann U., Schaefer H., Sterry W. Investigation of folllicular penetration of topically applied substances. Skin Pharmacol. Appl. Skin Physiol. 2001; 14(Suppl. 1)17–22
  • Lademann J., Richter H., Otberg N., Lawrenz F., Blume-Peytavi U., Sterry W. Application of a dermatological laser scanning confocal microscope for investigation in skin physiology. J. Laser Phys. 2003; 3: 46–51
  • Lademann J., Richter H., Schaefer U. F., Blume-Peytavi U., Teichmann A., Otberg N., Sterry W. Hair follicles—a long term reservoir for drug delivery. Skin Pharmacol. Physiol. 2007, 2006, in press
  • Lam C. W., James J. T., McCluskey R., Arepalli S., Hunter R. L. A review of carbon nanotubes toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol. 2006; 36: 189–217
  • Landsdown A.B.G., Taylor A. Zinc and titanium oxides: Promising UV-absorbers, but what influence do they have on the intact skin?. Int. J. Cosm. Sci. 1997; 19: 167–172
  • Lee K. P., Trochimowicz H. J., Reinhardt C. F. Pulmonary response of rats exposed for to titanium dioxide by inhalation for two years. Toxicol. Appl. Pharmacol. 1985; 79: 179–192
  • Limbach L.K., Li Y., Grass R. N., Brunner T. J., Hintermann M. A., Müller M., Gunther D., Stark W. J. Oxide nanoparticle uptake in human lung fibroblasts: Effects of particle size, agglomeration, and diffusion at low concentrations. Environ. Sci. Technol. 2005; 39: 9370–9376
  • Lipinski C.A., Lombardo F., Dominy B. W., Feeney P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev 2001; 46((1–3))3–26
  • Long T. C., Saleh N., Tilton R. D., Lowry G. V., Veronesi B. Titanium dioxide (P25) produces reactive oxygen species in immortalize microglia (BV2): implications for nanoparticles neurotoxicity. Environ. Sci. Technol. 2007, in press
  • Lopez C. Focus on the supramolecular structure of milk fat in dairy products. Reprod. Nutr. Develop. 2005; 45: 497–511
  • Luengo J., Weiss B., Schneider M., Ehlers A, Stracke F., Konig K., Kostka K. H., Lehr C. M., Schaefer U. F. Influence of nanoencapsulation on human skin transport of flufenamic acid. Skin Pharmacol. Physiol. 2006; 19(4)190–197
  • Magnusson B. M., Walters K. A., Roberts M. S. Veterinary drug delivery: Potential for skin penetration enhancement. Adv. Drug. Deliv. Rev. 2001; 50(3)205–27
  • Magnusson B. M., Anissimov Y. G., Cross S. E., Roberts M. S. Molecular size as the main determinant of solute maximum flux across the skin. J. Invest. Dermatol. 2004; 122(4)993–999
  • Maita K., Hirano M., Mitsumori K., Takahashi K., Shirasu Y. Subacute toxicity studies with zinc sulfate in mice and rats. J. Pestic. Sci. 1981; 6: 327–336
  • Mavon A., Miquel C., Lejeune O., Payre B., Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin. Pharmacol. Physiol 2007; 20: 10–20
  • Maynard A. D. Nanotechnology: a Research Strategy for Addressing Risk. Project on Emerging Nanotechnologies. 2006, Woodrow Wilson International Center for Scholars, June 2006. At: http://www.nanotechproject.org/file_download/77
  • Menzel F., Reinet T., Vogt J., Butz T. Investigations of percutaneous uptake of ultrafine TiO2 particles at the high energy ion nanoprobe LIPSION. Nucl. Instr. Meth. Phys. Res. B. 2004; 219–220: 82–86
  • Moghimi S. M., Hunter A. C., Murray J. C. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 2001; 53(2)283–318
  • Monteiro-Riviere N.A., Nemanich R. J., Inman A. O., Wang Y., Riviere J. E. Multi-wall carbon nanotube interactions with human epidermal keratinocytes. Toxicol. Lett. 2005a; 155: 377–384
  • Monteiro-Riviere N. A., Inman A. O., Wang Y. Y., Nemanich R. J. Surfactant effects on carbon nanotube interactions with human keratinocytes. Nanomed. Nanotech. Biol. Med. 2005b; 1: 2993–2999
  • Monteiro-Riviere N. A., Inman A. O. Challenges for assessing carbon nanomaterial toxicity to the skin. Carbon 2006; 44: 1070–1078
  • Mudway I. S., Duggan S. T., Vekataraman C., Habib G., Kelly F. J., Grigg J. Combustion of dried animal dung as biofuel results in the generation of highly redox-active particulates. Particul. Fibre Toxicol. 2005; 2(6)1–11
  • Nakagawa Y., Wakuri S., Sakamoto K., Tanaka N. The photogenotoxicity of titanium dioxide particles. Mut. Res. 1997; 394: 125–132
  • NCI. US National Cancer Institute Bioassay on titanium dioxide for possible carcinogenicity. Natl. Cancer Inst. Tech. Rep. Ser. 1979; 97: 1–117
  • Nel A., Xia T., Mädler L., Ning L. Toxic potential of materials at the nanolevel. Science 2006; 311: 622–627
  • Niki E., Yoshida Y., Saito Y., Noguchi N. Lipid peroxidation: mechanisms, inhibition and biological effects. Biochem. Biophys. Res. Commun. 2005; 338: 668–676
  • Nohynek G. J., Schaefer H. Benefit and risk of organic ultraviolet filters. Regul. Toxicol. Pharmacol. 2001; 33: 285–291
  • NTP/NIEHS. Developing Experimental Approaches for the Evaluation of Toxicological Interactions of Nanoscale Materials. 2004, Gainesville, FL, November 3–4, 2004. At: http://www.nanotoxicology.ufl.edu/workshop/images/NanoToxWorkshop.pdf
  • Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005a; 113: 823–839
  • Oberdörster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterisation the potential human health effects from exposure to nanomaterials: Elements of a screening strategy. Particul. Fibre Toxicol. 2005b; 2(8)1–35
  • Olivier V., Duval J. L., Hindie M., Poukletaut P., Nagel M. D. Comparative particle-induced cytotoxicity towards macrophages and fibroblasts. Cell Biol. Toxicol. 2003; 19: 145–159
  • Olson D. A., Burke J. M. Distributions of PM2.5 source strengths for cooking from the Research Triangle Park particulate matter panel study. Environ. Sci. Technol. 2006; 40(1)163–169
  • Otberg N., Richter H., Knuttel A., Schaefer H., Sterry W, Lademann J. Laser spectroscopic methods for the characterization of open and closed follicles. J. Laser Phys. 2004; 1(1)46–49
  • Padamwar M. N., Pokharkar V. B. Development of vitamin loaded liposomal formulations using factorial design approach: Drug deposition and stability. Int. J. Pharm. 2006; 320: 37–44
  • Paliwal. S., Menon G. K., Mitragotri S. Low-frequency sonophoresis: Ultrastructural basis for stratum corneum permeability assessed using quantum dots. J. Invest. Dermatol. 2006; 126: 1095–1101
  • Pflücker F., Wendel V., Hohenberg H., Gärtner E., Witt T., Pfeiffer S., Wepf R., Gers-Berlag H. The human stratum corneum layer: An effective barrier against dermal uptake of different forms of topically applied micronised titanium dioxide. Skin Pharm. Appl. Skin Physiol. 2001; 14(Suppl.1)92–97
  • Pirot F., Millet J., Kalia Y. N., Humbert P. In vitro study of percutaneous absorption, cutaneous bioavailability and bioequivalence of zinc and copper from five topical formulations. Skin Pharmacol. 1996; 9(4)259–269
  • Pogoda J., Preston-Martin S. Solar radiation, lip protection, and lip cancer risk in Los Angeles County women (California, United States). Cancer Causes Control 1996; 7(4)458–463
  • Popov A. P., Lademann J., Priezzhev A. V., Myllylä R. Effect of size of TiO2 nanoparticles embedded into stratum corneum on ultraviolet-A and ultraviolet-B sun-blocking properties of the skin. J. Biomed. Optics 2005; 10(6)1–9
  • Potts R. O., Guy R. H. Predicting skin permeability. Pharm. Res. 1992; 9(5)663–669
  • Roberts M. S. The latest science (including safety) on nanotechnology and skin penetration. CTFA/FDA Nanotechnology Public Meeting. 2006, Washington, D.C., September 2006. Available at: http://www.ctfa.org
  • Royal Society and Royal Academy of Engineering. Nanoscience and nanotechnologies, opportunities and uncertainties. 2004, Available at: http://www.royalsoc.ac.uk/policy/
  • Ryman-Rasmussen J. P., Riviere J. E., Monteiro-Riviere N.A. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J. Invest. Dermatol. 2007; 127(1)143–153
  • Ryman-Rasmussen J. P., Riviere J. E., Monteiro-Riviere N.A. Penetration of intact skin by quantum dots with diverse physicochemical properties. Toxicol. Sci. 2006; 91(1)159–165
  • Santos M. C., Mehnert W., Schaller M., Korting M. C., Gysier A., Haberland A., Schäfer-Korting M. Drug targeting by solid lipid nanoparticles for dermal use. J. Drug Target. 2002; 10(6)489–495
  • Sayes C. M., Warheit D. B., Austman K. D., Colvin V. I. Nano-TiO2 anatase vs. rutile particles: a cytotoxicity and inflammatory response study with human dermal fibroblasts and lung epithelial cells. Toxicologist 2006; 90(1)318
  • SCCNFP. Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers Concerning Titanium Dioxide. 2000, 24 October, 2000, European Commission, Brussels, Belgium. At: http://ec.europa.eu/health/ph_risk/committees/04_sccp/04_sccp_en.htm
  • SCCNFP. 2003a, Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers concerning Zinc Oxide COLIPA No. S 76. 24–25 June, 2003. European Commission, Brussels, Belgium. At: http://ec.europa.eu/health/ph_risk/committees/04_sccp/04_sccp_en.htm
  • SCCNFP. 2003b, Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers. Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation. 5th revision. 20 October, 2003. European Commission, Brussels, Belgium. At: http://ec.europa.eu/health/ph_risk/committees/04_sccp/04_sccp_en.htm
  • Schäfer-Korting M., Korting H. C., Ponce-Paschal E. Liposomal tretinoin for uncomplicated acne vulgaris. Clin. Invest. 1994; 72(12)1086–1091
  • Schaefer H., Redelmeier T. E. In vivo measurements of percutaneous absorption. Skin Barrier—Principles of Percutaneous Absorption, H. Schaefer, T.E. Redelmeier. S. Karger AG, BaselSwitzerland 1996; 120–129
  • Schaefer H., Redelmaier T., Nohynek G. J. Pharmacokinetics and topical application of drugs. Fitzpatrick's Dermatology in General Medicine, I.M. Freedberg, A.Z. Eisen, K. Wolff, F.K. Austen, L.A. Goldsmith, S.I. Katz. MacGraw-Hill, New York 2003; 2313–2318
  • SCENIHR. 2005, EU Scientific Committee on Emerging and Newly Identified Health Risks. Opinion on the appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. European Commission, Health and Consumer Protection, Directorate General, 28–29 September, 2005. At: http://ec.europa.eu/health/ph_risk/committees/04_scenihr/
  • Schilling M., Besselmann M., Müller M., Strecker M., Ringelstein E. B., Kiefer R. Predominant phagocytic activity of resident microglia over hematogenous macrophages following transient focal cerebral ischemia: An investigation using green fluorescent protein transgenic bone marrow chimeric mice. Experim. Neurol. 2005; 196(2)209–297
  • Shim. J., Seok Kang H., Park W. S., Han S. H., Kim J., Chang I. S. Transdermal delivery of minoxidil with block copolymer nanoparticles. J. Controlled Release 2004; 97(3)477–484
  • Schins R. P. Mechanism of genotoxicity of particles and fibres. Inhal. Toxicol. 2002; 14(1)57–78
  • Schreier H., Bouwstra J. A. Liposomes and niosomes as topical drug carriers: Dermal and transdermal drug delivery. Int. J. Pharm. 1994; 30: 1–15
  • Schulz J., Hohenberg F., Pflücker F., Gärtner B., Will T., Pfeiffer S., Wepf R., Wendel V., Gers-Berlag H., Wittern K. P. Distribution of sunscreens on skin. Adv. Drug Deliv. Rev. 2002; 54(Suppl. 1)S157–S163
  • Serpone N., Salinaro A., Emeline A. V. Deleterious effects of sunscreen titanium dioxide nanoparticles on DNA: Efforts to limit DNA damage by particle surface modification. Proc. SPIE 2001; 4258: 86–98
  • Shvedova A.A., Castranova V., Kisin E. R., Schwegler-Berry D., Murray A. R., Gandelsmann V. Z., Maynard A., Baron P. Z. Exposure to carbon nanotube material: Assessment of nanotube cytotoxicity using human keratinocyte cells. J. Toxicol Environ. Health A 2003; 66(20)1909–1926
  • Sinico C., Manconi M., Peppi M., Lai F., Valenti D., Fadda A. M. Liposomes as carriers for dermal delivery of tretinoin: In vitro evaluation of drug permeation and vesicle–skin interaction. J. Controlled Release 2005; 103: 123–136
  • Sonneville-Aubrun O., Simonnet J. T., L'Alloret F. Nanoemulsions: A new vehicle for skincare products. Adv. Colloid. Interface Sci. 2004; 108/109: 145–149
  • Stefanidou M., Maravelias C., Dona A. Zinc: A multi-purpose trace element. Arch. Toxicol. 2006; 80: 1–9
  • Stracke F., Weiss B., Lehr C. M., Konig K., Schaefer U. F., Schneider M. Multiphoton microscopy for the investigation of dermal penetration of nanoparticle-borne drugs. J. Invest. Dermatol. 2006; 126(10)2224–2233
  • Surber C., Wilhelm K. P., Hori M., Maibach H. I., Guy R. H. Optimization of topical therapy; Partitioning of drugs into stratum corneum. Pharm. Res. 1990; 7(12)1320–1324
  • Tan M. H., Commens C. A., Burnett L., Snitch P. A pilot study on the percutaneous absorption of microfine titanium dioxide from sunscreens. Austr. J. Dermatol. 1996; 37: 185–187
  • Teichmann A., Ossadnik M., Richter H., Sterry W., Lademann J. Semiquantitative determination of the penetration of a fluorescent hydrogel formulation into the hair follicle with and without follicular closure by microparticles by means of differential stripping. Skin Pharmacol. Physiol. 2006; 9(2)101–105
  • Telegraph. 2003, Spare us all from royal nanoangest—Roger Highfield reports on the Prince's distaste for Grey Goo 30 April, 2003. At: http://www.telegraph.co.uk/
  • TGA. 2006, Therapeutics Goods Administration, Australia. A review of the scientific literature on the safety of nanoparticles titanium dioxide or zinc oxide in sunscreens. 2nd February 2006. At: http://www.tga.gov.au
  • Thomas B. J., Finnin B. C. The transdermal revolution. Drug Discovery Today 2004; 9(14)697–703
  • Tinkle S.S, Antonini J. M., Rich B. A., Roberts J. R., Salmen R., DePree K., Adkins E. J. Skin as a route of exposure and sensitisation in chronic beryllium disease. Environ. Health Perspect. 2003; 111(9)1202–1208
  • Toll R., Jacobi U., Richter H., Lademann J., Schaefer H., Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J. Invest. Dermatol. 2004; 123: 168–176
  • Tsuji J. S., Maynard A. D., Howard P. C., James J. T., Lam C. W., Warheit D. B., Santamaria A. B. Research strategies for safety evaluation of nanomaterials, Part IV: Risk assessment of nanoparticles. Toxicol. Sci. 2006; 89: 42–50
  • Upadhyay P. Enhanced transdermal-immunization with diptheria-toxoid using local hyperthermia. Vaccine 2006; 24: 5593–5598
  • U.S. Environmental Prrotection Agency. Nanotechnology Workgroup / EPA's Science Policy Council. 2005a, Nanotechnology White Paper, 68–70, December 2, 2005. At: http://www.epa.gov/OSA/pdfs/EPA_nanotechnology_white_paper_external_review_draft_12-02-2005.pdf
  • U.S. Environmental Protection Agency. Toxicological review of zinc and compounds. 2005b, EPA/635/R-05/002. Available at: http://www.epa.gov/iris/toxreviews/
  • Van d en Bergh B.A.I., Vroom J., Gerritsen H., Junginger H. E., Bouwstra J. A. Interactions of elastic and rigid vesicles with human skin in vitro: Electron microscopy and two-photon excitation microscopy. Biochim. Biophys. Acta 1999; 1461: 155–173
  • Verma D. D., Verma S., Blume G., Fahr A. Particle size of liposomes influences dermal delivery of substances into the skin. Int. J. Pharm. 2003; 258: 141–151
  • Walker S. L., Hawk J.L.M, Young A. R. Acute and chronic effects of ultraviolet radiation on the skin. Fitzpatrick's Dermatology in General Medicine 6th, I.M. Freedberg, A.Z. Eisen, K. Wolff, F.K. Austen, L.A. Goldsmith, S.I. Katz. McGraw-Hill, New York 2003; 1275–1282
  • Wallace L., Howard-Reed C. Continuous monitoring of ultrafine, fine and coarse particles in a residence for 18 months in 1999–2000. J. Air Waste Manage. Assoc. 2002; 52: 828–844
  • Walter P., Welcomme E., Hallegot P., Zaluzec N., Deeb C., Castaing J., Veyssière P., Breniaux R., Leveque J. L., Tsoucaris G. Early use of nanotechnology for an ancient hair dyeing formula. Nano Lett. 2006, Electronic pre-publication, DOI: 10.1021/nl6149u
  • Walters K.A., Roberts M. S. Veterinary applications of skin penetration enhancers. Skin Penetration Enhancement., K.A. Walters, J. Hadgraft. Marcel Dekker, New York 1993; 331–350
  • Warheit D. B., Laurence B. R., Reed K. L., Roach D. H., Reynolds G. A.M., Webb T. R. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 2004; 77(1)117–125
  • Warheit D. B., Webbs T. R., Sayes C. M., Colvin V. L., Reed K. L. Pulmonary instillation studies with nanoscale TiO2, rods and dots in rats: Toxicity is not dependent upon particle size and surface area. Toxicol. Sci. 2006; 91(1)227–236
  • Wei A. L., Meng Z. Q. Induction of chromosome aberrations in cultured human lymphocytes treated with sand dust storm fine particles (PM2.5). Toxicol. Lett. 2006; 166(1)37–43, Pre-publication at: http://www.sciencedirect.com/science/journals/
  • Weigmann H. J., Lademann J., Meffert H., Schaefer H., Sterry W. Determination of the horny layer profile by tape stripping in combination with optical spectroscopy in the visible range as a prerequisite to quantify percutaneous absorption. Skin Pharmacol. Appl. Skin Physiol. 1999; 12: 34–45
  • WHO 1998, INTERSUN, The Global UV Project, Protection Against Exposure to Ultraviolet Radiation, World Health Organisation, Geneva, Switzerland. At: http://www.who.org
  • Wiebert P., Sanchez-Crespo A., Seitz J., Falk R., Philipson K., Kreyling W. G., Moeller W., Sommerer K., Larsson S., Svartengren M. Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur. Respir. J. 2006a; 28(2)286–290
  • Wiebert P., Sanchez-Crespo A., Falk R., Philipson K., Lundlin A., Larsson S., Moeller W., Kreyling W. G., Svartengren M. No significant translocation of inhaled 35-nm carbon particles to the circulation in humans. Inhal. Toxicol. 2006b; 18(10)741–747
  • Wissing S. A., Müller R. H. Cosmetic applications for solid lipid nanoparticles (SLN). Int. J. Pharm. 2003; 254(1)65–68
  • Yamamoto A., Honma R., Sumita M., Hanawa K. Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J. Biomed. Mater. Res. 2004; 68A: 244–256
  • Yoshikawa S. Biological response to a foreign body. J. Jpn. Soc. Biomater. 1991; 9: 94–103
  • Yu H. Y., Liao H. M. Triamcinolone permeation from different liposome formulations through rat skin in vitro. Int. J. Pharm. 1996; 127: 1–7
  • Zhai H., Maibach H. I. Effects of occlusion on percutaneous absorption. Skin Pharmacol. Appl. Skin Physiol. 2001; 14: 1–10
  • Zhang Y., So M. K., Rao J. Protease-modulated cellular uptake of quantum dots. Nano. Lett. 2006; 6: 1988–1992

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.